NO993180D0 - N-(pyridinylamino)isoindoler og beslektede forbindelser - Google Patents
N-(pyridinylamino)isoindoler og beslektede forbindelserInfo
- Publication number
- NO993180D0 NO993180D0 NO993180A NO993180A NO993180D0 NO 993180 D0 NO993180 D0 NO 993180D0 NO 993180 A NO993180 A NO 993180A NO 993180 A NO993180 A NO 993180A NO 993180 D0 NO993180 D0 NO 993180D0
- Authority
- NO
- Norway
- Prior art keywords
- pyridinylamino
- related compounds
- isoindoles
- isoindolines
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77430896A | 1996-12-27 | 1996-12-27 | |
| US08/959,789 US6004977A (en) | 1996-12-27 | 1997-10-29 | N-(pyridinylamino) isoindolines and related compounds |
| PCT/US1997/020591 WO1998029407A2 (en) | 1996-12-27 | 1997-11-13 | N-(pyridinylamino)isoindolines for treating alzheimer's and depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993180D0 true NO993180D0 (no) | 1999-06-25 |
| NO993180L NO993180L (no) | 1999-08-26 |
Family
ID=27118867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993180A NO993180L (no) | 1996-12-27 | 1999-06-25 | N-(pyridinylamino)isoindoler og beslektede forbindelser |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0950056B1 (no) |
| JP (1) | JP4256937B2 (no) |
| KR (1) | KR20000062358A (no) |
| AT (1) | ATE224387T1 (no) |
| AU (1) | AU720466B2 (no) |
| BR (1) | BR9714189A (no) |
| CA (1) | CA2276203C (no) |
| DE (1) | DE69715668T2 (no) |
| DK (1) | DK0950056T3 (no) |
| ES (1) | ES2179377T3 (no) |
| HU (1) | HUP0000783A2 (no) |
| IL (1) | IL130642A0 (no) |
| NO (1) | NO993180L (no) |
| PT (1) | PT950056E (no) |
| WO (1) | WO1998029407A2 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6772195B1 (en) | 1999-10-29 | 2004-08-03 | Electronic Arts, Inc. | Chat clusters for a virtual world application |
| WO2001087834A1 (fr) * | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Antagoniste de l'hormone de concentration de la melanine |
| KR20060009686A (ko) * | 2004-07-26 | 2006-02-01 | 엘지이노텍 주식회사 | 반도체 발광소자 및 그 제조방법 |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| JP5484914B2 (ja) | 2007-01-22 | 2014-05-07 | ジーティーエックス・インコーポレイテッド | 核内受容体結合剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0287982B1 (en) * | 1987-04-24 | 1994-12-07 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| FI95466C (fi) * | 1989-08-02 | 1996-02-12 | Hoechst Roussel Pharma | Menetelmä terapeuttisesti aktiivisten 2,3-dihydro-1-(pyridyyliamino)indolien valmistamiseksi |
| US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
| US5328920A (en) * | 1991-04-17 | 1994-07-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted (pyridinylamino)-indoles |
| US5177088A (en) * | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
-
1997
- 1997-11-13 IL IL13064297A patent/IL130642A0/xx unknown
- 1997-11-13 EP EP97948250A patent/EP0950056B1/en not_active Expired - Lifetime
- 1997-11-13 JP JP52999098A patent/JP4256937B2/ja not_active Expired - Fee Related
- 1997-11-13 AU AU54349/98A patent/AU720466B2/en not_active Ceased
- 1997-11-13 PT PT97948250T patent/PT950056E/pt unknown
- 1997-11-13 DK DK97948250T patent/DK0950056T3/da active
- 1997-11-13 ES ES97948250T patent/ES2179377T3/es not_active Expired - Lifetime
- 1997-11-13 AT AT97948250T patent/ATE224387T1/de not_active IP Right Cessation
- 1997-11-13 DE DE69715668T patent/DE69715668T2/de not_active Expired - Fee Related
- 1997-11-13 CA CA002276203A patent/CA2276203C/en not_active Expired - Fee Related
- 1997-11-13 BR BR9714189-5A patent/BR9714189A/pt not_active IP Right Cessation
- 1997-11-13 HU HU0000783A patent/HUP0000783A2/hu unknown
- 1997-11-13 WO PCT/US1997/020591 patent/WO1998029407A2/en active IP Right Grant
- 1997-11-13 KR KR1019997005846A patent/KR20000062358A/ko active IP Right Grant
-
1999
- 1999-06-25 NO NO993180A patent/NO993180L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2276203C (en) | 2003-07-22 |
| AU5434998A (en) | 1998-07-31 |
| DK0950056T3 (da) | 2003-01-27 |
| EP0950056B1 (en) | 2002-09-18 |
| CA2276203A1 (en) | 1998-07-09 |
| JP4256937B2 (ja) | 2009-04-22 |
| PT950056E (pt) | 2002-12-31 |
| HUP0000783A2 (hu) | 2001-04-28 |
| DE69715668T2 (de) | 2003-07-31 |
| WO1998029407A3 (en) | 1998-10-22 |
| ES2179377T3 (es) | 2003-01-16 |
| NO993180L (no) | 1999-08-26 |
| BR9714189A (pt) | 2000-02-29 |
| EP0950056A2 (en) | 1999-10-20 |
| JP2001511119A (ja) | 2001-08-07 |
| DE69715668D1 (de) | 2002-10-24 |
| WO1998029407A2 (en) | 1998-07-09 |
| AU720466B2 (en) | 2000-06-01 |
| ATE224387T1 (de) | 2002-10-15 |
| IL130642A0 (en) | 2000-06-01 |
| KR20000062358A (ko) | 2000-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE271058T1 (de) | Mycophenol bisphosponatverbindungen | |
| DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
| DK0758904T3 (da) | Fremgangsmåder og sammensætninger til behandling af glomerulonephritis | |
| TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
| MX9700557A (es) | Dihidrobenzofuranos. | |
| TR199600478A1 (tr) | Antidiabetik maddeler olarak, ikame edilmis N-(indol-2-karbonil)-B-alanimamidler ve türevleri. | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
| TR199901057T2 (no) | ||
| ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
| TR199701576T1 (xx) | N-aril-1,2,4,-triazolin-5-onlar. | |
| ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
| NO993180D0 (no) | N-(pyridinylamino)isoindoler og beslektede forbindelser | |
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| DK0880569T3 (da) | Kompositioner til behandling af jord, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| TR199901386T2 (en) | �midazopiridazinler. | |
| ATE215084T1 (de) | Imidazopyridin-azolidinone | |
| DK0720597T3 (da) | Triarylethylenderivater til terapeutisk anvendelse | |
| CA2302412A1 (en) | Aminoalkylphenol derivatives and related compounds | |
| NO973408L (no) | Fremgangsmåte til fremstilling av alkyl-tert.butyletere og di-n-buten fra feltbutaner | |
| NO975682L (no) | Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler | |
| CA2251545A1 (en) | Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors | |
| DE69421665T2 (de) | Anomere Fluorribosylamine | |
| DK1121439T3 (da) | Fremgangsmåder og præparater til inhibering af neoplastisk cellevækst |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |